✦ LIBER ✦

Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma

✍ Scribed by Jantunen, E; Putkonen, M; Nousiainen, T; Pelliniemi, T-T; Mahlamäki, E; Remes, K

Book ID: 110013554
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 115 KB
Volume: 31
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1703840

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermediate-Dose versus Low-Dose Cyclop

Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies

✍ Mehdi Hamadani; S. Thomas Kochuparambil; Salman Osman; Aaron Cumpston; Sonia Lea 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Comparative Cost-Effectiveness of Plerix

Comparative Cost-Effectiveness of Plerixafor Plus Granulocyte-Colony Stimulating Factor Versus Cyclophosphamide Plus Granulocyte-Colony Stimulating Factor for Autologous Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma

✍ C.J. Campen; A.M. Yeager; M.R. Green; E.P. Armstrong 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Peripheral blood progenitor cell mobiliz

Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage–colony-stimulating factor and granulocyte–colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation

✍ Asad Bashey; Michael Donohue; Lin Liu; Bridget Medina; Sue Corringham; Anita Iha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 150 KB

High-dose cyclophosphamide with or witho

High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity

✍ Gojo, I; Guo, C; Sarkodee-Adoo, C; Meisenberg, B; Fassas, A; Rapoport, A P; Cott 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Ifosamide, epirubicin and granulocyte co

Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma

✍ M. Arland; S. Leuner; S. Lange; R. Bartsch; C. Kahl; A. Florschütz; A. Franke; H 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract In general, the mobilization of peripheral blood progenitor cells (PBPC) in multiple myeloma (MM) patients is poor and is achieved in most cases by combined cyclophosphamide and G‐CSF. This study was performed to examine the efficacy of combined ifosfamide/epirubicine and G‐CSF for PBPC

Vinorelbine plus intermediate dose cyclo

Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma

✍ Mario Annunziata; Maria Celentano; Barbara Pocali; Maria Rosaria D’Amico; Salvat 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 172 KB